Europe & Central Asia

Afghanistan

Decades of conflict have ruined Afghanistan’s economy and infrastructure and many people rely on humanitarian aid.

266,500

outpatient consultations

70,500

births assisted

6,900

major surgical interventions

 

Europe & Central Asia

Albania

MSF first worked in Albania in 1998 and closed its projects in 2000.

 

Europe & Central Asia

Armenia

We are focusing on implementing new regimens for patients with multidrug-resistant tuberculosis (MDR-TB) in Armenia, which has one of the highest rates of the disease in the world.

58

patients started on treatment for MDR-TB

 

Europe & Central Asia

Azerbaijan

After ten years, MSF ended work in Azerbaijan in March 2001.

 

Europe & Central Asia

Belarus

We are working with the Ministry of Health in Belarus to improve adherence to treatment for patients with multidrug-resistant tuberculosis (MDR-TB).

31

patients started on treatment for MDR-TB

 

Europe & Central Asia

Belgium

Since the closure of the ‘Jungle’ camp in Calais (France) in October 2016, Belgium has seen a slow but steady rise of migrants and refugees in need of material and mental support.

525

individual mental health consultations

53

group mental health sessions

 

Europe & Central Asia

Bosnia and Herzegovina

After a decade working with populations affected by the Balkan wars, we ended our work in Bosnia and Herzegovina in 2001. In 2018, we returned to assist migrants and refugees escaping war and persecution in the Middle East, Asia and Africa.

 

Europe & Central Asia

Bulgaria

MSF first worked in Bulgaria in 1981 and closed its projects in 2015.

 

Europe & Central Asia

Croatia

MSF closed its projects in Croatia in 1998.

 

Europe & Central Asia

France

In Paris, northern France and at the borders with Italy and Spain, migrants and refugees encounter policies and practices aimed at preventing them from settling or claiming their rights.

10

NO. STAFF IN 2017

1987

YEAR MSF FIRST WORKED IN THE COUNTRY

 

Europe & Central Asia

Georgia

Multidrug-resistant tuberculosis (MDR-TB) is a major public health issue in Georgia: 12 per cent of all new patients and 39 per cent of those who have previously been treated for TB have a multidrug-resistant form of the disease.

54

patients started on treatment for MDR-TB

 

Europe & Central Asia

Germany

MSF worked in Germany in 2017 to introduce a system of peer counselling for asylum seekers as part of a pilot project handed over to St Josef hospital in Schweinfurt, Bavaria.

2017

YEAR MSF FIRST WORKED IN THE COUNTRY